"This is a blatant attempt at rent-seeking by an obvious vested interest. We know that the pharmaceutical industry has been lobbying hard to hamper the growth of e-cigarettes so it comes as no surprise to find Glaxo using the tired old gateway argument. The truth is that e-cigarettes will only "seriously disadvantage" the NRT market if they work better as quitting aids. In my experience—and the experience of countless other people—e-cigarettes are much better substitutes for smoking. If they were really a "gateway" to smoking, e-cigarettes would be good for companies like Glaxo as they would create more smokers (NRT companies need there to be smokers just as much as cigarette companies do)."

A new published online ahead of print in the journal Addiction provides evidence that electronic cigarettes may have the potential to outperform nicotine replacement therapy (NRT) for self-assisted smoking cessation.

LAST：2014 newest stainless steel/copper mephisto rda atomizer refill cartomizer |NEXT：alibaba china suppliers newest authentic dual coils atomizer kanger aerotank turbo skype pyx036